Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Aug 1, 2010
235 Pages - Pub ID: KLI2684026
Share this report
Attention: There is an updated edition available for this report.
 
Online Download $3,995
Global Site License $7,990
Hard Copy Mail Delivery $4,395
Departmental Site License (one location, up to 10 users) $5,995

Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies' portfolios. They've also attracted the attention of insurance companies, retail outlets and the media. The global market for vaccines experienced strong growth through 2009 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.

Kalorama Information has been closely following vaccine markets and since 2006 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected down the road. You can count on the objectivity and accuracy of our numbers and analysis—whether you're preparing a strategic presentation, benchmarking your company's performance against the competition, preparing a new product launch or seeking out an acquisition or a new partnership.

The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.

Included in this report are current market size and forecast for the following vaccines:

  • Pediatric Vaccines:
    • Combinations
    • Hepatitis
    • HIB
    • MMR
    • Pneumococcal
    • Poliovirus
    • Varicella
    • Other Pediatric
  • Adult Vaccines:
    • Cervical Cancer
    • Hepatitis
    • Influenza
    • Pneumococcal
    • Travel; DT; Misc.

Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report. In addition, the reort profiles key competitors in the vaccine industry. Companies profiled in the report include:

  • AlphaVax, Inc.
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Bharat Biotech
  • Celldex Therapeutics
  • Crucell
  • Emergent biosolutions
  • GlaxoSmithKline
  • Medimmune
  • Merck & Co. Inc
  • Nabi Biopharmaceuticals
  • Novartis
  • Pfizer
  • Sanofi Pasteur

Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.

CHAPTER ONE: EXECUTIVE SUMMARY
  • The Global Vaccine Industry
    • Scope and Methodology
    • Overview
    • Pediatric Preventative Vaccines
  • The Market
  • Adult Preventative Vaccines
  • The Market
  • Total Market
  • Issues and Trends
CHAPTER TWO: INTRODUCTION TO VACCINES
  • A Brief History: The Development of Vaccines
  • The Immune Response
  • Mechanism of Action
  • Types of Vaccines
    • Attenuated (Weakened) Live Viruses
    • Killed (Inactivated) Viruses
    • Toxoid Vaccines
    • Genetically Engineered/Modified Vaccines
    • Subunit Vaccines
    • Conjugate Vaccines
    • DNA Vaccination
  • Vaccine Approval Process
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
  • Introduction
  • Childhood Immunization in the United States
    • Childhood Immunization Rates
    • Challenges to the Vaccine Delivery System
    • The Effect of U.S. Health Care Reform
    • Recommended Childhood Immunization Schedule
    • State Immunization Recommendations
    • United Nations Initiatives
    Pediatric Vaccine Products
    • BCG
    • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
    • Diphtheria
    • Pertussis
    • Tetanus
    • Hepatitis B
    • Poliomyelitis
    • Haemophilus Influenzae Type B
    • Hepatitis A
    • Measles, Mumps and Rubella
    • Measles
    • Mumps
    • Rubella
    • Meningococcal Disease
    • Pneumococcal Conjugate
    • Rotavirus
    • Varicella
  • Pediatric Vaccines in Development
  • Cost of Vaccines in the United States The World Market for Pediatric Preventive Vaccines
    • Total Market Size and Forecast
    • Hepatitis Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
    • Haemophilus Influenzae Type B Vaccine Market
      • Market Analysis
      • Leading Products and Competitors
    • Measles, Mumps and Rubella Vaccines
      • Market Analysis
    • Combination Vaccines Market
      • Market Analysis
      • Leading Products and Competitors
    • Pneumococcal Vaccine
      • Leading Products and Competitors
    • Poliovirus Vaccine
      • Market Analysi
      • Leading Products and Competitors
    • Varicella Vaccine
      • Market Analysis
      • Leading Products and Competitors
    • Other Vaccines Market
      • Market Analysis
      • Leading Products and Competitors
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
  • Introduction
  • Adult Vaccine-Preventable Diseases: Facts and Figures
  • Global Influenza Surveillance Program
  • Recommendations for Adult Immunizations
    • WHO International Health Regulations
  • Adult Vaccine Products
    • BCG
    • Cervical Cancer
    • Cholera
    • Diphtheria-Tetanus
    • Hepatitis
      • Hepatitis A
      • Hepatitis B
    • Influenza
    • Japanese Encephalitis
    • Pneumococcal Disease
    • Rabies
    • Shingles
    • Typhoid Fever
    • Yellow Fever
  • Adult Vaccines in Development
  • Total Market Size and Forecast
    • Cervical Cancer Market
    • Market Analysis
    • Leading Products and Competitors
    • Hepatitis Market
    • Market Analysis
    • Leading Products and Competitors
    • Influenza Vaccine Market
    • Market Analysis
    • Leading Products and Competitors
    • Market Analysis
    • Leading Products and Competitors
    • Travel, DT, and Miscellaneous Vaccine Market
    • Market Analysis
    • Leading Products and Competitors
CHAPTER FIVE: VACCINES MARKET SUMMARY
  • Trends Driving the Vaccines Market
  • Market Size and Forecast
  • Vaccine Sales by Region
  • Vaccine Market Competitors
  • Pediatric Vaccines
  • Major Manufacturer’s Market Share
  • Adult Vaccines
  • Major Manufacturer’s Market Share
CHAPTER SIX: ISSUES AND TRENDS
  • Vaccine Safety
  • Refusal to Immunize
  • Obesity
  • Post-Licensure Surveillance
  • Vaccine Adverse Event Reporting System
  • The Vaccine Safety Datalink Project
  • Phase IV studies
  • The Vaccine Injury Compensation Program
  • Countermeasures Injury Compensation Program
  • World Health Organization
  • Other Initiatives
  • The Future of Vaccine Safety
    • Vaccine Shortages
    • Preventing Shortages in the Developed Countries
    • Financial incentives
    • Equitable pricing
    • Vaccine stockpiles
    • Preventing Shortages in Developing Nations
    • Vaccine bonds
    • Preventing Pandemics
    • U.S. National Vaccine Plan
  • Vaccines and Bioterrorism
  • Overview
  • Project Bioshield Act
  • National Bio and Agro-Defense Facility
  • Vaccine Treatment and Evaluation Units
  • Anthrax
  • Smallpox
  • Tularemia
  • Viral Hemorrhagic Fevers
  • DNA Vaccination
  • Innovations in Vaccine Delivery Systems
    • Edible Vaccines
    • Mucosal Delivery
    • Intranasal Delivery
    • Vaccine Patches
    • Vaccine Chips
  • Innovations in Vaccine Production
    • Tobacco Plants
    • Insects
    • Nanoparticle Systems
CHAPTER SEVEN: COMPANY PROFILES
  • AlphaVax, Inc.
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Bavarian Nordic A/S
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Baxter Healthcare
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Bharat Biotech
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Celldex Therapeutics
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Crucell
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Emergent Biosolutions
    • History and Lines of Business
    • Strategic Acquisition and Alliance
    • Vaccine Products
    • Financial
  • GlaxoSmithKline
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Medimmune
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Merck & Co. Inc
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Nabi Biopharmaceuticals
    • History and Lines of Business
    • Strategic Alliance
    • Vaccine Products
    • Financial Information
  • Novartis
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information
  • Pfizer
    • History and Lines of Business
    • Strategic alliances
    • Vaccine Products
    • Financial Information
  • Sanofi Pasteur
    • History and Lines of Business
    • Strategic Alliances
    • Vaccine Products
    • Financial Information

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: World Market for Pediatric Vaccines 2005-2014 Revenues (in millions)

  • Figure 1-2: World Market for Adult Vaccines 2005-2014 Revenues (in millions)
CHAPTER TWO: INTRODUCTION TO VACCINES

  • Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2009

  • Table 2-2: Vaccine-Preventable Diseases, June 2010

  • Table 2-3: VAERS Table of Reportable Events Following Vaccination
CHAPTER THREE PEDIATRIC PREVENTIVE VACCINES

  • Table 3-1: Global Immunization Rates by Vaccine Type 2008

  • Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2002-2008

  • Table 3-3 : U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2010

  • Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2010

  • Table 3-5: Selected Pediatric Vaccines in Development, June 2010

  • Table 3-6 : World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others) 2005-2014 Revenues (in millions)

  • Figure 3-1: Market Share of Pediatric Vaccines by Type 2009

  • Figure 3-2: Market Share of Pediatric Vaccines, by Type 2014

  • Table 3-7 : World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in millions)

  • Table 3-8: World Pediatric Hepatitis Vaccine Market 2005-2014 World Hib Vaccine Market, 2005-2014

  • Table 3-10: World MMR Vaccines Market 2005-2014

  • Table 3-11 World Combination Vaccines Market 2005-2014

  • Table 3-12 World Pediatric Pneumococcal Vaccine Market 2005-2014

  • Table 3-13 World Poliovirus Vaccine Market 2005-2014

  • Table 3-14 World Varicella Vaccine Market 2005-2014

  • Table 3-15 World Pediatric Other Vaccines Market 2005-2014
CHAPTER FOUR ADULT PREVENTIVE VACCINES

  • Table 4-1 Universal Adult Immunization Schedule 2010

  • Table 4-2 Adult Immunization Schedule for Populations with Special Medical Conditions, 2010

  • Table 4-3 Initiatives to Require HPV Vaccination by U.S. State, 2010

  • Table 4-4 WHO Pandemic Classification Schedule Selected Adult Preventive Vaccines in Development, 2010

  • Table 4-6 World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2005-2014 Revenues (in millions)

  • Figure 4-1 Market Share of Adult Vaccines, by Type, 2009

  • Figure 4-2 Market Share of Adult Vaccines, by Type, 2014

  • Table 4-7 World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in millions)

  • Table 4-8 World Cervical CancerVaccine Market 2005-2014

  • Table 4-9 World Hepatitis Vaccine Market 2005-2014 World Influenza Vaccine Market 2005-2014

  • Table 4-11 CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010)

  • Table 4-12 2009 Estimated Population by Region and Selected Age Group (in millions)

  • Table 4-13 World Pneumococcal Vaccine Market 2005-2014 World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2005-2014 160
CHAPTER FIVE VACCINES MARKET SUMMARY

  • Figure 5-1 Sales Growth of Vaccines vs. Pharmaceuticals 2005-2014

  • Figure 5-2 World Market for Vaccines by Type 2005-2014

  • Table 5-1 The World Vaccines Market by Vaccine Type 2005-2014 Revenues (in millions

  • Figure 5-3 World Market for Vaccines Share by Type, 2005, 2009 and 2014

  • Table 5-2 The World Vaccines Market by Region 2005-2014 Revenues (in millions)

  • Table 5-3 Major Manufacturers’ Shares of the World Vaccine Market, 2009

  • Figure 5-3 2009 World Vaccines Market Share, by Leading Competitors

  • Table 5-4 Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2009

  • Figure 5-5 Market Share of Pediatric Vaccines Market, 2009

  • Table 5-5 Major Manufacturer’s Shares of the World Adult Vaccine Market 2009

  • Figure 5-6: Market Share of Adult Vaccines Market 2009
CHAPTER SIX ISSUES AND TRENDS

  • Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.